StockVaultSandbox
ScreenerSectorsLearnMethodDesign
Request access
StockVaultSandbox
ScreenerSectorsLearnMethodDesign
Request access
Back to screenerCompare

ASTERDM — ASTER DM HEALTHCARE LTD.

Structural concernsWeak profitability

Price History

Data as of 26 Jun 2026· via fincrux

How ASTERDM has traded over time.

Is the price reasonable right now?

Where today's price sits within its own 12-month range — context, not advice.

Upper end of its 12-month range84% of range

Trading about 44% above its 12-month low and near recent highs — historically pricier territory for this stock. It sits above its 200-day average, the longer-term trend.

₹536 low₹815 high
vs 50-day avg
+3.2%
vs 200-day avg
+15.8%
Beginner mode
Plain English, with everything explained

ASTERDM

NSE

ASTER DM HEALTHCARE LTD.

Healthcare / Hospitals

₹769.05
0.00%
last close
0%
Quality Score
A mixed pictureBig money selling

ASTER DM HEALTHCARE LTD. passes 2 of 3 checks. There's something to like here, but also a few things to be careful about. Read the four checks below before forming a view.

Company size
₹37737.00 Cr
Price tag
115.0×
Money it earns
8.9%

The four quality checks

Every company faces the same four checks. Tap the ? on any term to learn what it means.

01

Is the company drowning in loans?

We check how much the company has borrowed versus its own money. Too much debt makes a business fragile when times get tough.

Aligned

The company keeps its borrowing under control. That's a sign of a sturdy balance sheet.

D/E 0.31goal < 0.5
02

Does it make good money, consistently?

We look at how much profit the company squeezes out of its owners' money, averaged over three years — not just one lucky quarter.

Divergent

Profits relative to the money invested are on the weaker side over the last few years.

ROE 8.9%goal > 15% (3y avg)
03

Is the big, smart money buying in?

Large professional investors (global funds and Indian mutual funds) do deep research before buying. We track whether they've been adding or trimming their stake.

Aligned

Professional investors have been holding steady or buying more — a quiet vote of confidence.

FII+DII 44.8%goal stable or rising (2Q)
04

Is the price reasonable right now?

Even a great company can be a bad buy if it's overpriced. We compare today's price tag to how this company has typically been priced over the past five years.

No data

We don't have enough reliable data to run this check yet, so we're leaving it open rather than guessing.

Data unavailablegoal P/E < 5y median

What we noticed

Observations from the data — not recommendations.

  • Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clini…
Data as of 26 Jun 2026· via fincrux

StockVault is an educational research and mathematical-modeling sandbox. It presents structural readings derived from public data and does not provide investment advice, recommendations, or target prices. Figures shown are illustrative and delayed. Markets carry risk; decisions are your own.

Balance Sheet

What ASTERDM owns and owes over the years. Tap the ? on any line to learn what it means.

Line itemFigures in ₹ crore
ItemMar '22Mar '23Mar '24Mar '25Mar '26
Borrowings8951,0721,2161,5741,347
Equity Capital500500500500518
Reserves2,0812,2572,4202,4663,848
Total Assets3,7624,1024,5384,9656,340
Total Liabilities3,7624,1024,5384,9656,340

Borrowings rising

Total borrowings are up about 51% over the last 5 years — worth watching alongside how much it earns.

Periodic Performance

Yearly net profit for ASTERDM — does it earn money consistently?

Consistently profitable

Every one of the last 5 years has been profitable — a sign of durable earnings.

₹90 Cr
₹173 Cr
₹157 Cr
₹6,209 Cr
₹268 Cr
Mar '22Mar '23Mar '24Mar '25Mar '26
rev ₹1,116 Crrev ₹1,534 Crrev ₹2,036 Crrev ₹2,320 Crrev ₹2,616 Cr
Net profit · annualProfitLoss

Strengths & Risks

What the numbers say is good and bad about ASTERDM — observations, not recommendations.

Strengths

3
  • Keeps borrowing low relative to its own capital — a sturdy balance sheet.
  • Large professional investors have been holding steady or adding to their stake.
  • Profitable in every one of the last 5 years.

Risks

2
  • Profit generated from the money invested has been on the weaker side.
  • Sits near the top of its 12-month range — historically pricier territory for this stock.

Institutional Ownership Trend

FII and DII holding across the last four quarters.

FII· Foreign institutions
17.2%-2.5 pp
DII· Domestic institutions
27.6%+2.3 pp
Jun '25Sep '25Dec '25Mar '26

Sector Peers

How others in Healthcare / Hospitals score on the same four guardrails.

  • APOLLOHOSPAPOLLO HOSPITALS ENTER. L100
  • NHNARAYANA HRUDAYALAYA LTD.69
  • FORTISFORTIS HEALTHCARE LTD63
  • MAXHEALTHMAX HEALTHCARE INS LTD47
  • KIMSKRISHNA INST OF MED SCI L47
View the full sector